Concepedia

Lawrence D. Durack

LD

Statistics

Publications

16

Citations

1.6K

H-Index

15

Active since

1989

Affiliations

University of Washington(Current)

Fred Hutch Cancer Center

University of Washington Medical Center

Pacific Northwest National Laboratory

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Lawrence D. Durack is an author at University of Washington specializing in health sciences, radiation oncology, and radiation therapy.

Top concepts

Publications per year

1989–2006

16

Publications

16

Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

Dana C. Matthews, Frederick R. Appelbaum, Janet F. Eary et al. · Blood · 1999 · 300 citations

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.

S Y Liu, JF Eary, Stephen H. Petersdorf et al. · Journal of Clinical Oncology · 1998 · 290 citations

, , +19

A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

Oliver W. Press, Janet F. Eary, Ted Gooley et al. · Blood · 2000 · 261 citations

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

Ajay K. Gopal, Joseph G. Rajendran, Stephen H. Petersdorf et al. · Blood · 2002 · 207 citations · Full text

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis

Ajay K. Gopal, Theodore A. Gooley, David G. Maloney et al. · Blood · 2003 · 203 citations · Full text

1–5 of 16